Could Ketamine Help Treat Alcohol Addiction? A Short Course Showed Effects Months Later
Evidence review & editorial synthesis
Ketamine is best known for anesthesia and, more recently, its rapid effects in severe depression. But it may have another psychiatric use: helping people with alcohol addiction stay away from alcohol.
In a small randomized trial, adults with severe alcohol use disorder received just three weekly ketamine infusions. Months later, they were still recording more alcohol-free days than participants receiving placebo. A new analysis of that trial now suggests the strongest outcomes may have occurred when ketamine was paired with structured psychological support.
The result is promising because the treatment itself lasted only a few weeks.
Three infusions, more abstinent days six months later
The original KARE trial enrolled 96 adults with severe alcohol use disorder who had already stopped drinking after detoxification.
Participants were randomly assigned to three weekly intravenous infusions of ketamine at 0.8 mg/kg or saline placebo. Each drug condition was also paired with either relapse-prevention-oriented psychological support or alcohol education.
At six months, the ketamine groups had an average of 10.1 percentage points more abstinent days than the placebo groups. The largest arm-to-arm difference occurred between ketamine plus psychological therapy and saline plus alcohol education, at 15.9 percentage points.
The new 2026 analysis looked at the data through endpoints often used in regulatory alcohol-treatment trials.
Across weeks 17 to 24, people receiving ketamine plus psychological support were abstinent on 78.5% of days, compared with 57.8% in the saline-plus-education group. That was a difference of 20.7 percentage points.
At weeks 21 to 24, the adjusted difference reached 26.9 percentage points.
This was four to six months after the brief treatment course had ended.
Could ketamine create a window for changing addiction?
That durability is what makes ketamine unusual.
Conventional AUD medications are generally taken continuously. Naltrexone reduces alcohol's rewarding effects and craving, while acamprosate helps maintain abstinence after withdrawal. Disulfiram creates an unpleasant reaction when alcohol is consumed.
Ketamine is different. It blocks NMDA receptors and rapidly alters glutamate signaling, with downstream effects on synaptic plasticity. Researchers have proposed that this temporary period of increased plasticity could make entrenched patterns of thought, learning and behavior more changeable.
That creates an appealing model for ketamine-assisted psychotherapy: briefly alter the brain state, then use psychological treatment while behavior may be unusually flexible.
But this remains a hypothesis. A separate 2026 analysis of the KARE trial found that the intensity of ketamine's altered-consciousness effects did not statistically explain its abstinence benefit. A dramatic subjective experience may therefore not be the essential ingredient.
The wider evidence is promising, but not definitive
KARE is not the only positive signal.
A 2026 meta-analysis pooled 15 randomized trials of ketamine for substance use disorders, involving 798 participants. Ketamine was associated with substantially higher odds of abstinence during the first month, with an odds ratio of 3.27.
But the longer-term result was less convincing. Between one and six months, the pooled odds ratio was 1.74 and did not reach statistical significance.
Reviews focused specifically on alcohol use disorder reach a similar conclusion: several studies report improvements in abstinence, craving or drinking, particularly when ketamine is combined with psychotherapy, but protocols and results vary widely.
That makes the new KARE analysis intriguing rather than decisive.
The study also reported that 50.0% of patients in the ketamine-plus-support arm had no heavy drinking days at weeks 21 to 24, compared with 26.1% in the comparison arm. However, that difference was not statistically significant.
Ketamine is not ready to replace standard alcohol treatment
Alcohol use disorder already has evidence-based treatments, including behavioral therapy and the approved medications naltrexone, acamprosate and disulfiram.
Ketamine remains experimental for this indication.
The current evidence comes from relatively small studies, and the new analysis is post hoc. Researchers still need to establish which patients benefit, whether psychotherapy is essential, how many sessions are optimal, how long effects persist and how safely ketamine can be used in a population already vulnerable to substance misuse.
Still, the concept is unusually interesting.
Most addiction medications work while someone keeps taking them. Ketamine raises the possibility that a short, supervised intervention could instead help produce a longer-lasting change in drinking behavior.
Three infusions are nowhere near enough evidence to declare alcohol addiction solved. But if larger trials reproduce the months-long abstinence signal, ketamine could represent a very different kind of addiction treatment.
Scientific References & Further Reading
- Anchor Study: “No Heavy Drinking Days and Percentage of Days Abstinent in a Randomized Trial of Adjunctive Ketamine for Alcohol Use Disorder: Secondary Analysis of the KARE Trial.” (Morgan CJ, Nutt DJ. 2026 preprint. doi:10.64898/2026.09.26.26363761.)
- Original KARE Trial: “Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder.” (Grabski M, McAndrew A, Lawn W, et al. Am J Psychiatry. 2022;179(2):152-162. doi:10.1176/appi.ajp.2021.21030277.)
- 2026 Meta-Analysis: “Ketamine for substance use disorders: a systematic review and meta-analysis.” (Fang Y, Yang X, Zhao Y, et al. 2026. PMID:42540381.)
- AUD Systematic Review: “Safety and efficacy of ketamine for the treatment of patients with alcohol use disorder: a systematic review.” (Am J Drug Alcohol Abuse. 2025. doi:10.1080/00952990.2025.2535559. PMID:40773768.)
- Ketamine and AUD Review: “Ketamine Treatment for Alcohol Use Disorder: A Systematic Review.” (Kelson M, et al. 2023. PMID:37273364.)
- Standard AUD Treatment: “Treatment for Alcohol Problems: Finding and Getting Help.” (National Institute on Alcohol Abuse and Alcoholism. Alcohol treatment guidance.)
Disclaimer: This article is for informational purposes only and does not constitute medical advice. It is not a substitute for diagnosis, treatment, or individualized medical care.

